Company voluntarily recalls blood pressure medication over cancer concerns

Posted: Updated:
EDISON -

Another company is voluntarily recalling its blood pressure medication over concerns the tablets might contain trace amounts of a cancer-causing ingredient.

Aurobindo Pharma USA is voluntarily recalling 80 lots of its Valsartan tablets because they might include a human carcinogen called N-nitrosodiethylamine, or NDEA.

The company says they have not received any reports of illnesses or adverse effects.

According to the recall notice, patients taking the recalled medication should contact their pharmacist or doctor to find an alternative medication, but should not stop using the tablets until they find a suitable substitute.

Immediately stopping medication without an alternative could be dangerous.

The recall comes about two months after Teva Pharmaceuticals recalled two of its blood pressure drugs for the same concerns.

sorry to interrupt
your first 20 are free
Access to News 12 is free for Optimum, Comcast®, Spectrum Networks® and Service ElectricSM customers.
Please enjoy 20 complimentary views of articles, photos, and videos during the next 30 days.
you have reached your 20 view limit
Access to News 12 is free for Optimum, Comcast®, Spectrum Networks® and Service ElectricSM customers.
Please login or create an account to continue enjoying News12.
Our sign-up page is undergoing maintenance and is not currently available. However, you will be given direct access to news12.com while we complete our upgrade.
When we are back up and running you will be prompted at that time to complete your sign in. Until then, enjoy the local news, weather, traffic and more that's "as local as local news gets."